Low dose of targeted drug might improve cancer-killing virus therapy
Tuesday, June 17, 2014 - 11:05
in Health & Medicine
Giving low doses of the targeted agent bortezomib with a cancer-killing virus might improve the effectiveness of the virus as a treatment for cancer with little added toxicity. The findings support the testing of this combination therapy in a clinical trial.